Bulimia Nervosa Market Global Professional In-depth Analysis by Treatment (psychotherapy, drug therapy and other) – Forecast Till 2023
Bulimia Nervosa Market – Overview
The cases for bulimia nervosa have been on the risen chiefly due to factors such as unrealistic body type expectations, increased peer pressure coupled with the rise in alcoholism. The market is anticipated to observe a renewed growth surge primarily due to the rise in research towards the treatment of the disorder and launch of drugs that are increasingly effective in counteracting the symptoms of the disorder.
The market is predicted to surge at a CAGR of 4.5% approximately in the upcoming forecast period. The incidence of eating disorders in the society have risen sharply especially cases related to bulimia nervosa.
Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/1417
The market has significantly counterbalanced the market advantages and thus is encouraging an upsurge in the number of firms in the market. The modification of the product range in the market is growing the opportunity for the progress of the market. The capacity to utilize the economies of scale is additionally proving to be beneficial for comprehensive market growth.
Competitive Analysis
The market is at an optimally beneficial level and will be capable of generating better value for the firms in the market and its shareholders. The management propensities in the market are strengthening the level of growth that can be achieved in the current market scenario. The growth patterns are revised in tandem to the customer likings to realize the greatest growth, and in the long run, viability.
The major contenders in the bulimia nervosa market are,
- Stryker (U.S)
- Philips Healthcare (U.S)
- Abbott (U.S)
- Siemens Healthcare GmbH (Germany)
- General Electric Company (U.K)
- Johnson & Johnson Services Inc. (U.S)
- Covidien Ltd(Ireland) and Penumbra Inc. (U.S) to name a few.
Segmental Analysis
The segmentation of the bulimia nervosa market globally is carried out on the basis of treatment and region.
The market is further segmented into the type of treatment into drug therapy, psychotherapy, and other. The psychotherapy is further sub-segmented into maudsley family therapy and other. The drug therapy is further sub-segmented into antidepressants and other.
The regions counted in the market are North America, Europe, Asia Pacific, Africa, and the Middle East.
Intended Audience
- Pharmaceutical companies
- Bulimia Nervosa treatment centers
- Research and Development (R&D) Companies
- Government and Independent Research Laboratories
- Contract Research Organizations (CROs)
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Browse Complete Report@ https://www.marketresearchfuture.com/reports/bulimia-nervosa-market-1417
Global Bulimia Nervosa Market – Regional Analysis
On regional basis, North America has the leading bulimia nervosa market due to increasing prevalence of this disorder in North America. 6.2 million People are suffering with this bulimia nervosa in North America majority of them are young adults. Beside this unmet need of medication and technological advances is the other factor for growth of this market in North America.
According to World Population Ageing Report, in 2017, there are an estimated 962 million people aged 60 or over globally, which is 13% of the total global population. According to the population reference bureau, the number of Americans ageing 65 and older is projected to more than double from 46 million in 2015 to over 98 million by 2060. According to the StastsCan, 2015, over 5.7 million Canadians have aged 65 and older, which was 16.1 % of Canadian population. According to Statistics Canada projections, this trend will only increase. By 2031, one in four Canadians will be over 65 age. According to the WHO, 2015, Asia’s elderly population is projected to reach nearly 923 million by 2050. Growing geriatric is fuelling the number of patients suffering from cardiovascular diseases owing to the high susceptibility of this population pool to developing cardiovascular diseases. Increasing geriatric population will increase the market for cardiovascular devices since they are more vulnerable towards cardiovascular diseases such as hypertension, stroke, and other diseases. Moreover, increasing healthcare expenditure has provided fuel for the growth of the market.
North America is followed by Europe in bulimia nervosa market. Increasing number of diabetic population, patents suffering from other cardiovascular diseases, technological advances and well developed healthcare sector has led to grow this market in Europe. Asia Pacific is the fastest growing market due to a huge population base and increasing prevalence of diabetes and other bulimia nervosa causing disease. The Middle East & Africa has the least market for bulimia nervosa.
TABLE OF CONTENTS
- Introduction
- Research Methodology
- Market Dynamics
- Market Factor Analysis
- Global Bulimia Nervosa Market, By Treatment
- Global Pain Management Devices Market, By Region
- Competitive Landscape
- Company Profile
…to be Continued.
Ask for an Exclusive Discount at https://www.marketresearchfuture.com/check-discount/1417
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future.
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar, Pune
+1 646 845 9312